文章
https://www.watson-int.cn/wp-content/uploads/2024/07/linagliptin-impurity-24.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-07 00:51:10 2024-07-07 00:51:10 Linagliptin Impurity 24 CAS号 N/A
https://www.watson-int.cn/wp-content/uploads/2024/07/linagliptin-impurity-26.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-07 00:51:10 2024-07-07 00:51:10 Linagliptin Impurity 26 CAS号 N/A 2024年7月7日
668270-11-9,Linagliptin
https://www.watson-int.cn/wp-content/uploads/2024/07/linagliptin-s-isomer.jpg
510
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-07 00:40:33 2024-07-07 00:40:33 Linagliptin S-Isomer CAS号 668270-11-9 2024年7月7日
1646355-34-1,Linagliptin
https://www.watson-int.cn/wp-content/uploads/2024/07/linagliptin-impurity-18.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-07 00:40:33 2024-07-07 00:40:33 Linagliptin Impurity 18 CAS号 1646355-34-1
https://www.watson-int.cn/wp-content/uploads/2024/07/linagliptin-impurity-i.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-07 00:40:33 2024-07-07 00:40:33 Linagliptin Impurity I CAS号 N/A
https://www.watson-int.cn/wp-content/uploads/2024/07/linagliptin-metabolite-cd1790.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-07 00:36:41 2024-07-07 00:36:41 Linagliptin Metabolite CD1790 CAS号 N/A 2024年7月7日
668270-12-0,Linagliptin
https://www.watson-int.cn/wp-content/uploads/2024/07/linagliptin.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-07 00:36:10 2024-07-07 00:36:10 Linagliptin CAS号 668270-12-0 2024年7月7日
1638744-06-5,Linagliptin
https://www.watson-int.cn/wp-content/uploads/2024/07/linagliptin-impurity-s.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-07 00:36:10 2024-07-07 00:36:10 Linagliptin Impurity S CAS号 1638744-06-5 2024年7月7日
666816-98-4,Linagliptin
https://www.watson-int.cn/wp-content/uploads/2024/07/linagliptin-related-compound-a.jpg
510
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-07 00:26:40 2024-07-07 00:26:40 Linagliptin Related Compound A CAS号 666816-98-4 2024年7月7日
2137744-33-1,Linagliptin
https://www.watson-int.cn/wp-content/uploads/2024/07/linagliptin-related-compound-c.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-07 00:26:40 2024-07-07 00:26:40 Linagliptin Related Compound C CAS号 2137744-33-1
Scroll to top